99863-45-3

Usage

Uses

Used in Pharmaceutical Industry:
N-(2,2-Dimethoxyethyl)cyclohexanamine is used as a building block for the synthesis of pharmaceuticals due to its unique properties and functional groups. It can contribute to the development of new drugs and therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical sector, N-(2,2-Dimethoxyethyl)cyclohexanamine is used as a precursor in the synthesis of agrochemicals. Its specific properties make it suitable for creating compounds that can be utilized in crop protection and other agricultural applications.
Used in Specialty Chemicals:
N-(2,2-Dimethoxyethyl)cyclohexanamine is also used in the production of specialty chemicals. Its unique structure and functional groups allow it to be a valuable component in the synthesis of various specialty chemicals for different applications.
The specific uses and properties of N-(2,2-Dimethoxyethyl)cyclohexanamine may vary depending on the intended application, and further research and development are necessary to fully explore its potential.

Upstream product

• 97-97-2 chloroacetaldehyde dimethyl acetal 
• 108-91-8 cyclohexylamine 
• 51673-84-8 dimethoxyacetaldehyde 
• 108-94-1 cyclohexanone 
• 22483-09-6 2,2-dimethoxyethylamine 

Downstream Products

• 1035229-41-4 N-cyclohexyl-N-(2,2-dimethoxyethyl)acrylamide 
• 1035229-13-0 N-cyclohexyl-N-(2,2-dimethoxyethyl)-3-phenethoxypropanamide 
• 1201640-56-3 N-cyclohexyl-N-(2,2-dimethoxyethyl)-3-(3-(1-ethyl-1H-1,2,3-triazol-4-yl)phenethoxy)propanamide 
• 1201640-64-3 N-cyclohexyl-N-(2,2-dimethoxyethyl)-3-(3-(1-methyl-1H-1,2,3-triazol-4-yl)phenethoxy)propanamide 
• 1201640-73-4 N-cyclohexyl-N-(2,2-dimethoxyethyl)-3-(3-(2-methyl-2H-tetrazol-5-yl)phenethoxy)propanamide 
• 1201640-75-6 N-cyclohexyl-N-(2,2-dimethoxyethyl)-3-(3-(1-methyl-1H-tetrazol-5-yl)phenethoxy)propanamide 
• 1201641-44-2 N-cyclohexyl-N-(2,2-dimethoxyethyl)-3-(3-(1,5-dimethyl-1H-pyrazol-4-yl)phenethoxy)propanamide 
• 1201640-36-9 3-(3-bromophenethoxy)-N-cyclohexyl-N-(2,2-dimethoxyethyl)propanamide 
• 1201640-77-8 3-(3-cyanophenethoxy)-N-cyclohexyl-N-(2,2-dimethoxyethyl)propanamide 

Relevant academic research and scientific papers

SMYD2 INHIBITORS

The present disclosure generally relates to compounds having cellular anti-proliferative activities, and more particularly relates to compounds which inhibit the activity of human SMYD2, a SET and MYND domain-containing protein lysine methyltransferase.

From isonitriles to unsaturated NHC complexes of gold, palladium and platinum

In a modular template synthesis, unsaturated NHC complexes of gold, palladium and platinum were synthesized from simple metal salts, isonitriles and amines with acetal or ketal groups. Upon the addition of amines with tethered acetal or ketal moieties to the metal-activated isonitrile, first nitrogen acyclic carbene (NAC) complexes are formed. These undergo ring closure and elimination to the unsaturated NHC complexes upon addition of acid. This simple strategy opens an attractive and fast approach to NHC complexes of gold, palladium and platinum. The modular approach allows a fast modification and is well-suited for the synthesis of unsymetrically and symmetrically substituted unsaturated NHC complexes.

Discovery of A-893, A New Cell-Active Benzoxazinone Inhibitor of Lysine Methyltransferase SMYD2

A lack of useful small molecule tools has precluded thorough interrogation of the biological function of SMYD2, a lysine methyltransferase with known tumor-suppressor substrates. Systematic exploration of the structure-activity relationships of a previous

BENZOXAZINONE DERIVATIVES ACTING AS BETA2-ADRENORECEPTOR AGONIST FOR THE TREATMENT OF RESPIRATORY DISORDERS

The present invention provides a compound of formula (I), wherein W, R1, R2 and R3 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

AMINE DERIVATIVES AND THEIR USE IN BETA-2-ADRENORECEPTOR MEDIATED DISEASES

The present invention provides compounds of formula (I), wherein k, Ar, R2, R3, R4, R5, R4', R5', R6, R7, A, D, m and E are as defined in the specification, processes